Vitamin D and its Possible Relationship to Neuroprotection in COVID-19: Evidence in the Literature
Authors:
- Saray Quintero-FabiánSQSaray Quintero-Fabián
- Cindy BandalaCindy Bandala
- Luz Adriana Pichardo-MacíasLPLuz Adriana Pichardo-Macías
- Itzel Jatziri Contreras-GarcíaICItzel Jatziri Contreras-García
- Saúl Gómez-ManzoSGSaúl Gómez-Manzo
- Beatriz Hernández-OchoaBHBeatriz Hernández-Ochoa
- José Arturo Martínez-OrozcoJMJosé Arturo Martínez-Orozco
- Iván Ignacio- MejíaIMIván Ignacio- Mejía
- Noemí Cárdenas-RodríguezNoemí Cárdenas-Rodríguez
- 1 June 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 22 (16) , 1346-1368
Abstract
Vitamin D is a hormone involved in the regulation of important biological processes such as signal transduction, immune response, metabolic regulation and also in the nervous and vascular systems. To date, coronavirus disease 2019 (COVID-19) infection does not have a specific treatment. However, various drugs have been proposed, including those that attenuate the intense inflammatory response, and recently, the use of vitamin D, in clinical trials, as part of the treatment of COVID-19 has provided promising results. It has been observed in some clinical studies that the use of cholecalciferol (vitamin D3) and its two metabolites the circulating form, calcidiol or calcifediol (25-hydroxycalciferol, 25-(OH)-D), and the active form, calcitriol (1,25-(OH)2-D), in different doses, improve the clinical manifestations, prognosis, and survival of patients infected with COVID-19 probably because of its anti-inflammatory, antiviral and lung-protective action. In relation to the central nervous system (CNS) it has been shown, in clinical studies, that vitamin D is beneficial in some neurological and psychiatric conditions because of its anti-inflammatory and antioxidant properties, modulation of neurotransmitters actions, and regulation of calcium homeostasis between other mechanisms. It has been shown that COVID-19 infection induces CNS complications such as headache, anosmia, ageusia, neuropathy, encephalitis, stroke, thrombosis, cerebral hemorrhages, cytotoxic lesions, and psychiatric conditions and it has been proposed that the use of dietary supplements, as vitamin and minerals, can be adjuvants in this disease. In this review, the evidence of the possible role of vitamin D, and its metabolites, as a protector against the neurological manifestations of COVID-19 was summarized.Keywords
Funding Information
- Hospital Central Militar, SEDENA (068/2021)
This publication has 168 references indexed in Scilit:
- Cationic Host Defence Peptides: Potential as Antiviral TherapeuticsBioDrugs, 2013
- Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric diseaseFrontiers in Neuroendocrinology, 2013
- Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental IllnessArchives of General Psychiatry, 2010
- Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin–angiotensin systemClinica Chimica Acta, 2010
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProceedings of the National Academy of Sciences, 2009
- Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?The FASEB Journal, 2007
- Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial ResponseScience, 2006
- Metabolism of Vitamin D3 by Human CYP27A1Biochemical and Biophysical Research Communications, 2000
- Vitamin D is a membrane antioxidant Ability to inhibit iron‐dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer actionFEBS Letters, 1993
- Photometabolism of 7-dehydrocholesterol to previtamin D3 in skinBiochemical and Biophysical Research Communications, 1977